These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7558783)
1. Soluble cytokine receptors in disease. Barak V Isr J Med Sci; 1995 Sep; 31(9):565-71. PubMed ID: 7558783 [No Abstract] [Full Text] [Related]
2. Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors. Williams G; Giroir BP New Horiz; 1995 May; 3(2):276-87. PubMed ID: 7583169 [TBL] [Abstract][Full Text] [Related]
3. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. Gallea-Robache S; Morand V; Millet S; Bruneau JM; Bhatnagar N; Chouaib S; Roman-Roman S Cytokine; 1997 May; 9(5):340-6. PubMed ID: 9195133 [TBL] [Abstract][Full Text] [Related]
4. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Jones SA; Rose-John S Biochim Biophys Acta; 2002 Nov; 1592(3):251-63. PubMed ID: 12421670 [TBL] [Abstract][Full Text] [Related]
5. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Hirano T; Matsuda T; Nakajima K Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593 [TBL] [Abstract][Full Text] [Related]
6. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin. West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520 [TBL] [Abstract][Full Text] [Related]
7. Effect of soluble interleukin-6 receptor on interleukin-6 synthesis in human skin fibroblasts. Cichy J; Rose-John S; Pryjma J; Travis J Biochem Biophys Res Commun; 1996 Oct; 227(2):318-21. PubMed ID: 8878515 [TBL] [Abstract][Full Text] [Related]
8. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Kaneyama K; Segami N; Sun W; Sato J; Fujimura K Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832 [TBL] [Abstract][Full Text] [Related]
9. The soluble interleukin-6 receptor. Rose-John S; Ehlers M; Grötzinger J; Müllberg J Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529 [No Abstract] [Full Text] [Related]
10. Interleukin 4 and interleukin 13: same response, different receptors. Callard RE; Matthews DJ; Hibbert LM Biochem Soc Trans; 1997 May; 25(2):451-5. PubMed ID: 9191134 [No Abstract] [Full Text] [Related]
11. [Cytokines and anti-cytokines in inflammatory rheumatism]. Dayer JM Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):173S-180S. PubMed ID: 7858569 [TBL] [Abstract][Full Text] [Related]
12. Mice deficient in tumor necrosis factor receptors p55 and p75, interleukin-4, or inducible nitric oxide synthase are susceptible to endotoxin-induced uveitis. Smith JR; Hart PH; Coster DJ; Williams KA Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):658-61. PubMed ID: 9501881 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo. Holtmann MH; Douni E; Schütz M; Zeller G; Mudter J; Lehr HA; Gerspach J; Scheurich P; Galle PR; Kollias G; Neurath MF Eur J Immunol; 2002 Nov; 32(11):3142-51. PubMed ID: 12555659 [TBL] [Abstract][Full Text] [Related]
14. [Cytokine binding proteins: a model of interleukin 6]. Brailly H; Montero-Julian FA Arch Inst Pasteur Tunis; 1994; 71(3-4):535-48. PubMed ID: 8801856 [No Abstract] [Full Text] [Related]
15. B7.2 on activated and phagocytic microglia in the facial axotomy model: regulation by interleukin-1 receptor type 1, tumor necrosis factor receptors 1 and 2 and endotoxin. Bohatschek M; Kloss CU; Pfeffer K; Bluethmann H; Raivich G J Neuroimmunol; 2004 Nov; 156(1-2):132-45. PubMed ID: 15465604 [TBL] [Abstract][Full Text] [Related]
16. Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels. Pollmächer T; Korth C; Schreiber W; Hermann D; Mullington J Cytokine; 1996 Oct; 8(10):799-803. PubMed ID: 8980882 [TBL] [Abstract][Full Text] [Related]
17. Time- and dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation. Könemann S; Bölling T; Malath J; Kolkmeyer A; Janke K; Riesenbeck D; Hesselmann S; Diallo R; Vormoor J; Willich N; Schuck A Int J Radiat Biol; 2003 Nov; 79(11):897-909. PubMed ID: 14698958 [TBL] [Abstract][Full Text] [Related]
18. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha. Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543 [TBL] [Abstract][Full Text] [Related]
19. Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential. Lauffer L; Kanzy EJ; Köhler R; Kurrle R; Enssle K; Seiler FR Behring Inst Mitt; 1995 Jun; (96):21-31. PubMed ID: 7575349 [TBL] [Abstract][Full Text] [Related]
20. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]